Association between osteopontin promoter gene polymorphisms and haplotypes with risk of diabetic nephropathy

Journal of Clinical Medicine

Volumn 4, Issue 6, 2015, Pages 1281-1292

  Cheema, Balneek Singh ^a   Iyengar, Sreenivasa ^a   Sharma, Rajni ^a   Kohli, Harbir Singh ^a   Bhansali, Anil ^a   Khullar, Madhu ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Diabetic nephropathy; EGFR; Haplotypes; Osteopontin promoter gene polymorphism; Type 2 diabetes

Indexed keywords

OSTEOPONTIN;

ADULT; ARTICLE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; GLOMERULUS FILTRATION RATE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REAL TIME POLYMERASE CHAIN REACTION; URINALYSIS;

EID: 85048835051     PISSN: None     EISSN: 20770383     Source Type: Journal    
DOI: 10.3390/jcm4061281     Document Type: Article

References (27)

1. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414, 813-820.
2. Quinn, M.; Angelico, M.C.; Warram, J.H.; Krolewski, A.S. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia 1996, 39, 940-945.
3. Dronavalli, S.; Duka, I.; Bakris, G.L. The pathogenesis of diabetic nephropathy. Nat. Clin. Pract. Endocrinol. Metab. 2008, 4, 444-452.
4. Junaid, A.; Amara, F.M. Osteopontin: Correlation with interstitial fibrosis in human diabetic kidney and PI3-kinase-mediated enhancement of expression by glucose in human proximal tubular epithelial cells. Histopathology 2004, 44, 136-146.
5. Kramer, A.B.; Ricardo, S.D.; Kelly, D.J.; Waanders, F.; van Goor, H.; Navis, G. Modulation of osteopontin in proteinuria-induced renal interstitial fibrosis. J. Pathol. 2005, 207, 483-492.
6. Ziyadeh, F.N.; Goldfarb, S. The renal tubulointerstitium in diabetes mellitus. Kidney Int. 1991, 39, 464-475.
7. Giacopelli, F.; Marciano, R.; Pistorio, A.; Catarsi, P.; Canini, S.; Karsenty, G.; Ravazzolo, R. Polymorphisms in the osteopontin promoter affect its transcriptional activity. Physiol. Genomics 2004, 20, 87-96.
8. Trivedi, T.; Franek, B.S.; Green, S.L.; Kariuki, S.N.; Kumabe, M.; Mikolaitis, R.A.; Jolly, M.; Utset, T.O.; Niewold, T.B. Osteopontin alleles are associated with clinical characteristics in systemic lupus erythematosus. J. Biomed. Biotechnol. 2011, 2011, doi:10.1155/2011/802581.
9. Maver, A.; Medica, I.; Salobir, B.; Tercelj, M.; Peterlin, B. Genetic variation in osteopontin gene is associated with susceptibility to sarcoidosis in Slovenian population. Dis. Markers 2009, 27, 295-302.
10. Erdogan, H.; Mir, S.; Berdeli, A.; Aksu, N. Renal scarring and osteopontin gene C/T polymorphism in children with primary vesicoureteral reflux. Indian Pediatr. 2012, 49, 311-313.
11. Cheema, B.S.; Iyengar, S.; Ahluwalia, T.S.; Kohli, H.S.; Sharma, R.; Shah, V.N.; Bhansali, A.; Sakhuja, V.; Khullar, M. Association of an osteopontin gene promoter polymorphism with susceptibility to diabetic nephropathy in Asian Indians. Clin. Chim. Acta 2012, 413, 1600-1604.
12. Hummelshoj, T.; Ryder, L.P.; Madsen, H.O.; Odum, N.; Svejgaard, A. A functional polymorphism in the Eta-1 promoter is associated with allele specific binding to the transcription factor Sp1 and elevated gene expression. Mol. Immunol. 2006, 43, 980-986.
13. Gao, B.; Yasui, T.; Itoh, Y.; Li, Z.; Okada, A.; Tozawa, K.; Hayashi, Y.; Kohri, K. Association of osteopontin gene haplotypes with nephrolithiasis. Kidney Int. 2007, 72, 592-598.
14. Hendig, D.; Arndt, M.; Szliska, C.; Kleesiek, K.; Götting, C. SPP1 promoter polymorphisms: Identification of the first modifier gene for pseudoxanthomaelasticum. Clin. Che. 2007, 53, 829-836.
15. Chen, J.; Wu, Q.; Lu, Y.; Xu, T.; Huang, Y.; Ribas, J.; Ni, X.; Hu, G.; Huang, F.; Zhou, L.; et al. SPP1 promoter polymorphisms and glioma risk in a Chinese Han population. J. Hum. Genet 2010, 55, 456-461.
16. Glas, J.; Seiderer, J.; Bayrle, C.; Wetzke, M.; Fries, C.; Tillack, C.; Olszak, T.; Beigel, F.; Steib, C.; Friedrich, M.; et al. The Role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PLoS ONE 2011, 6, e29309.
17. Chiu, Y.W.; Tu, H.F.; Wang, I.K.; Wu, C.H.; Chang, K.W.; Liu, T.Y.; Kao, S.Y. The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol. 2010, 46, 302-306.
18. Court Lab Hardy-Weinberg Equilibrium (HWE) Calculator. Available online: http://www.tufts.edu/~mcourt01/Documents/Court%20lab%20-%20HW%20calculator.xls (accessed on 1 July 2012).
19. Matthew Stephens Lab. Available online: http://stephenslab.uchicago.edu/software.html (accessed on 1 July 2012).
20. Haploview Software. Available online: http://www.broad.mit.edu/mpg/haploview/ (accessed on 1 July 2012).
21. Nakayama, H.; Nagai, H.; Matsumoto, K.; Oguro, R.; Sugimoto, K.; Kamide K Ohishi, M.; Katsuya, T.; Okamoto, H.; Maeda, M.; et al. Association between osteopontin promoter variants and diastolic dysfunction in hypertensive heart in the Japanese population. Hypertens. Res. 2011, 34, 1141-1146.
22. Liu, C.C.; Huang, S.P.; Tsai, L.Y.; Wu, W.J.; Juo, S.H.; Chou, Y.H.; Huang, C.H.; Wu, M.T. The impact of osteopontin promoter polymorphisms on the risk of calcium urolithiasis. Clin. Chim. Acta 2010, 411, 739-743.
23. Pegoraro, E.; Hoffman, E.P.; Piva, L.; Gavassini, B.F.; Cagnin, S.; Ermani, M.; Bello, L.; Soraru, G.; Pacchioni, B.; Bonifati, M.D.; et al.SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy. Neurology 2011, 76, 219-226.
24. D'Alfonso, S.; Barizzone, N.; Giordano, M.; Chiocchetti, A.; Magnani, C.; Castelli, L.; Indelicato, M.; Giacopelli, F.; Marchini, M.; Scorza, R.; et al. Two single-nucleotide polymorphisms in the 5′ and 3′ ends of the osteopontin gene contribute to susceptibility to systemic lupus erythematosus. Arthritis Rheum. 2005, 52, 539-547.
25. Marciano, R.; D'Annunzio, G.; Minuto, N.; Pasquali, L.; Santamaria, A.; di Duca, M.; Ravazzolo, R.; Lorini, R. Association of alleles at polymorphic sites in the osteopontin encoding gene in young type 1 diabetic patients. Clin. Immunol. 2009, 131, 84-91.
26. Heuer, J.G.; Breyer, M.D. Osteopontin in diabetic nephropathy: Signpost or road? Kidney Int. 2010, 77, 565-566.
27. Bird, T.D.; Jarvik, G.P.; Wood, N.W. Genetic association studies. Neurology 2001, 57, 1153-1154.